|
GS185131: GO:0044699 single-organism process
|
|
GS170581: MP:0008987 abnormal liver lobule morphology
|
|
GS168997: MP:0009640 abnormal renal tubule epithelium morphology
|
|
GS177044: HP:0001922 Vacuolated lymphocytes
|
|
GS36462: Whole Brain Gene expression correlates of Morphine - Postural Effects in Males BXD
|
|
GS136137: lithogenic gene 18 (Lith18, Published QTL Chr 8)
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS175101: HP:0000280 Coarse facial features
|
|
GS136045: insulin dependent diabetes susceptibility 22 (Idd22, Published QTL Chr 8)
|
|
GS205780: GO:0044723 single-organism carbohydrate metabolic process
|
|
GS169830: MP:0005384 cellular phenotype
|
|
GS172294: HP:0001510 Growth delay
|
|
GS171241: HP:0002492 Abnormality of the corticospinal tract
|
|
GS174134: HP:0002012 Abnormality of the abdominal organs
|
|
GS135547: CD4 T cell subset 3 (Cd4ts3, Published QTL Chr 8)
|
|
GS123265: Estradiol interacting genes (MeSH:D004958) in CTD
|
|
GS163581: MP:0001004 abnormal retinal photoreceptor morphology
|
|
GS166394: MP:0003728 abnormal retinal photoreceptor layer morphology
|
|
GS167046: MP:0003881 abnormal nephron morphology
|
|
GS124417: Propylthiouracil interacting genes (MeSH:D011441) in CTD
|
|
GS171596: HP:0000164 Abnormality of the teeth
|
|
GS176151: HP:0000256 Macrocephaly
|
|
GS166576: MP:0004081 abnormal globus pallidus morphology
|
|
GS176385: HP:0001249 Intellectual disability
|
|
GS172701: HP:0002650 Scoliosis
|
|
GS170969: HP:0000157 Abnormality of the tongue
|
|
GS135948: HDL QTL 16 (Hdlq16, Published QTL Chr 8)
|
|
GS164483: MP:0005220 abnormal exocrine pancreas morphology
|
|
GS176107: HP:0000929 Abnormality of the skull
|
|
GS136657: skeletal muscle weight 16 (Skmw16, Published QTL Chr 8)
|
|
GS166858: MP:0000685 abnormal immune system morphology
|
|
GS172843: HP:0000481 Abnormality of the cornea
|
|
GS167519: MP:0002802 abnormal discrimination learning
|
|
GS126646: Carbon Tetrachloride interacting genes (MeSH:D002251) in CTD
|
|
GS176098: HP:0000927 Abnormality of skeletal maturation
|
|
GS171718: HP:0002808 Kyphosis
|
|
GS176033: HP:0011039 Abnormality of the helix
|
|
GS171980: HP:0007232 Spinocerebellar tract disease in lower limbs
|
|
GS169585: MP:0001413 abnormal response to new environment
|
|
GS172728: HP:0008850 Severe postnatal growth retardation
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS201251: GO:0044424 intracellular part
|
|
GS170569: MP:0005404 abnormal axon morphology
|
|
GS176916: HP:0004437 Cranial hyperostosis
|
|
GS164333: MP:0000516 abnormal renal/urinary system morphology
|
|
GS135449: bone length and organs 5 (Bod5, Published QTL Chr 8)
|
|
GS174338: HP:0002719 Recurrent infections
|
|
GS207982: GO:0005764 lysosome
|
|
GS175466: HP:0007893 Progressive retinal degeneration
|
|
GS171802: HP:0009553 Abnormality of the hairline
|
|
GS209163: GO:0005773 vacuole
|
|
GS173812: HP:0000738 Hallucinations
|
|
GS163824: MP:0001259 abnormal body weight
|
|
GS173355: HP:0002205 Recurrent respiratory infections
|
|
GS176615: HP:0000277 Abnormality of the mandible
|
|
GS163432: MP:0006069 abnormal retinal neuronal layer morphology
|
|
GS173048: HP:0005557 Abnormality of the zygomatic arch
|
|
GS173557: HP:0005372 Abnormality of B cell physiology
|
|
GS163994: MP:0008248 abnormal mononuclear phagocyte morphology
|
|
GS175601: HP:0002086 Abnormality of the respiratory system
|
|
GS170933: HP:0001288 Gait disturbance
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS174506: HP:0100712 Abnormality of the lumbar spine
|
|
GS175546: HP:0010885 Aseptic necrosis
|
|
GS176591: HP:0001276 Hypertonia
|
|
GS173449: HP:0002683 Abnormality of the calvaria
|
|
GS174756: HP:0011947 Respiratory tract infection
|
|
GS201367: GO:0019538 protein metabolic process
|
|
GS84205: chronic alcohol withdrawal severity (Published QTL, Chr 8)
|
|
GS168413: MP:0004292 abnormal spiral ligament fibrocyte morphology
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS171708: HP:0000359 Abnormality of the inner ear
|
|
GS186744: GO:0043226 organelle
|
|
GS128597: Ethanol Induced Ataxia Chr#8
|
|
GS182835: GO:0005622 intracellular
|
|
GS189224: GO:0007610 behavior
|
|
GS135540: cerebellum weight 2 (Cbm2, Published QTL Chr 8)
|
|
GS168683: MP:0000598 abnormal liver morphology
|
|
GS171645: HP:0011843 Abnormality of skeletal physiology
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS170954: HP:0000885 Broad ribs
|
|
GS173019: HP:0000819 Diabetes mellitus
|
|
GS172928: HP:0011729 Abnormality of joint mobility
|
|
GS206742: GO:0043167 ion binding
|
|
GS165603: MP:0008265 abnormal hippocampus CA2 region morphology
|
|
GS175500: HP:0000517 Abnormality of the lens
|
|
GS173334: HP:0000687 Widely spaced teeth
|
|
GS171600: HP:0000168 Abnormality of the gingiva
|
|
GS172906: HP:0003319 Abnormality of the cervical spine
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS164960: MP:0002856 abnormal vestibular ganglion morphology
|
|
GS176588: HP:0001272 Cerebellar atrophy
|
|
GS173512: HP:0000306 Abnormality of the chin
|
|
GS121381: fumonisin B1 interacting genes (MeSH:C056933) in CTD
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS135972: wound healing/regeneration 1 (Heal1, Published QTL Chr 8)
|
|
GS171815: HP:0001574 Abnormality of the integument
|
|
GS170791: HP:0010978 Abnormality of immune system physiology
|
|
GS173187: HP:0007772 Impaired smooth pursuit
|
|
GS181473: GO:0005488 binding
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS168155: MP:0005502 abnormal renal/urinary system physiology
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS166540: MP:0009820 abnormal liver vasculature morphology
|
|
GS171647: HP:0011844 Abnormal appendicular skeleton morphology
|
|
GS176229: HP:0004570 Increased vertebral height
|
|
GS168016: MP:0003686 abnormal eye muscle morphology
|
|
GS174847: HP:0000940 Abnormal diaphysis morphology
|
|
GS169303: MP:0008250 abnormal myeloid leukocyte morphology
|
|
GS173288: HP:0000316 Hypertelorism
|
|
GS173403: HP:0002684 Thickened calvaria
|
|
GS172415: HP:0002240 Hepatomegaly
|
|
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS176462: HP:0100240 Synostosis of joints
|
|
GS175409: HP:0002070 Limb ataxia
|
|
GS128577: Ethanol induced LORR Chr# 8
|
|
GS163662: MP:0005277 abnormal brainstem morphology
|
|
GS165527: MP:0005378 growth/size phenotype
|
|
GS167466: MP:0002799 abnormal passive avoidance behavior
|
|
GS175529: HP:0000001 All
|
|
GS174507: HP:0100711 Abnormality of the thoracic spine
|
|
GS164448: MP:0005193 abnormal anterior eye segment morphology
|
|
GS176008: HP:0010701 Abnormal immunoglobulin level
|
|
GS177598: GO:0043412 macromolecule modification
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS174257: HP:0000309 Abnormality of the midface
|
|
GS35078: Striatum Gene expression correlates of Difference in time on rotarod between training and saline in Females & Males BXD
|
|
GS174926: HP:0000768 Pectus carinatum
|
|
GS166250: MP:0008247 abnormal mononuclear cell morphology
|
|
GS208012: GO:0044464 cell part
|
|
GS87380: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS162983: MP:0002356 abnormal spleen red pulp morphology
|
|
GS209597: GO:0005537 mannose binding
|
|
GS170980: HP:0011362 Abnormal hair quantity
|
|
GS168422: MP:0000716 abnormal immune system cell morphology
|
|
GS135589: P. chabaudi malaria resistance QTL 2 (Char2, Published QTL Chr 8)
|
|
GS198454: GO:0048029 monosaccharide binding
|
|
GS204027: GO:0044708 single-organism behavior
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS136032: induction of brown adipocytes 3 (Iba3, Published QTL Chr 8)
|
|
GS171791: HP:0000370 Abnormality of the middle ear
|
|
GS174385: HP:0002088 Abnormality of the lung
|
|
GS174721: HP:0000772 Abnormality of the ribs
|
|
GS167020: MP:0003956 abnormal body size
|
|
GS169535: MP:0005397 hematopoietic system phenotype
|
|
GS165789: MP:0005369 muscle phenotype
|
|
GS121965: Amiodarone interacting genes (MeSH:D000638) in CTD
|
|
GS173083: HP:0000492 Abnormality of the eyelid
|
|
GS176745: HP:0010866 Abdominal wall defect
|
|
GS169530: MP:0005390 skeleton phenotype
|
|
GS175665: HP:0006504 Abnormality involving the diaphyses of the limbs
|
|
GS199635: GO:0005622 intracellular
|
|
GS175571: HP:0011492 Abnormality of corneal stroma
|
|
GS167289: MP:0001463 abnormal spatial learning
|
|
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
|
|
GS169566: MP:0001092 abnormal trigeminal ganglion morphology
|
|
GS173792: HP:0002815 Abnormality of the knees
|
|
GS185006: GO:0015923 mannosidase activity
|
|
GS170285: MP:0004967 abnormal kidney epithelium morphology
|
|
GS174075: HP:0009121 Abnormal axial skeleton morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS167518: MP:0001312 abnormal cornea morphology
|
|
GS169386: MP:0002063 abnormal learning/memory/conditioning
|
|
GS201821: GO:0015923 mannosidase activity
|
|
GS172942: HP:0002942 Thoracic kyphosis
|
|
GS197314: GO:0000323 lytic vacuole
|
|
GS175539: HP:0007256 Abnormality of pyramidal motor function
|
|
GS172617: HP:0004313 Hypogammaglobulinemia
|
|
GS165615: MP:0002123 abnormal hematopoiesis
|
|
GS136390: autoimmune orchitis resistance 6 (Orch6, Published QTL Chr 8)
|
|
GS173147: HP:0011283 Abnormality of the metencephalon
|
|
GS179910: GO:0030246 carbohydrate binding
|
|
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
|
|
GS175594: HP:0011014 Abnormal glucose homeostasis
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS176172: HP:0001251 Ataxia
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS170961: HP:0000158 Macroglossia
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS169827: MP:0005387 immune system phenotype
|
|
GS170198: MP:0001614 abnormal blood vessel morphology
|
|
GS192655: GO:0005537 mannose binding
|
|
GS175096: HP:0000286 Epicanthus
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS135268: alopecia areata 3 (Alaa3, Published QTL Chr 8)
|
|
GS167759: MP:0000787 abnormal telencephalon morphology
|
|
GS175456: HP:0100037 Abnormality of the scalp hair
|
|
GS209291: GO:0046914 transition metal ion binding
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS172024: HP:0001369 Arthritis
|
|
GS173327: HP:0005368 Abnormality of humoral immunity
|
|
GS121369: Clofibric Acid interacting genes (MeSH:D002995) in CTD
|
|
GS86984: Table S2: The data provided represent genes showing differential expression using ANOVA. A. Genes showing main effect of strain. [DRG]
provisional
|
|
GS171661: HP:0000617 Abnormality of ocular smooth pursuit
|
|
GS165538: MP:0005377 hearing/vestibular/ear phenotype
|
|
GS171789: HP:0001392 Abnormality of the liver
|
|
GS192354: GO:0046914 transition metal ion binding
|
|
GS169095: MP:0004924 abnormal behavior
|
|
GS173337: HP:0000689 Dental malocclusion
|
|
GS168111: MP:0008114 abnormal Kupffer cell morphology
|
|
GS163101: MP:0008540 abnormal cerebrum morphology
|
|
GS170965: HP:0000153 Abnormality of the mouth
|
|
GS171204: HP:0011314 Abnormality of long bone morphology
|
|
GS172667: HP:0011805 Abnormality of muscle morphology
|
|
GS164022: MP:0008246 abnormal leukocyte morphology
|
|
GS175197: HP:0002066 Gait ataxia
|
|
GS174331: HP:0002715 Abnormality of the immune system
|
|
GS167217: MP:0001325 abnormal retina morphology
|
|
GS186836: GO:0008270 zinc ion binding
|
|
GS164530: MP:0000801 abnormal temporal lobe morphology
|
|
GS169658: MP:0002572 abnormal emotion/affect behavior
|
|
GS175304: HP:0000290 Abnormality of the forehead
|
|
GS177356: GO:0003674 molecular_function
|
|
GS188916: GO:0044723 single-organism carbohydrate metabolic process
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS199032: GO:0036211 protein modification process
|
|
GS176245: HP:0011443 Abnormality of coordination
|
|
GS136533: preaxial shift (Prxsh, Published QTL Chr 8)
|
|
GS175119: HP:0001881 Abnormality of leukocytes
|
|
GS209865: GO:0050890 cognition
|
|
GS175783: HP:0002503 Spinocerebellar tract degeneration
|
|
GS173666: HP:0005978 Type II diabetes mellitus
|
|
GS164446: MP:0005195 abnormal posterior eye segment morphology
|
|
GS208375: GO:0004559 alpha-mannosidase activity
|
|
GS136313: non-HDL QTL 1 (Nhdlq1, Published QTL Chr 8)
|
|
GS206091: GO:0007610 behavior
|
|
GS87137: Table S2: List of probe-sets of genes differentially expressed among the four inbred strains of mice. Gene Ranks [DRG]
provisional
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS135989: Hfe modifier 2 (Hfem2, Published QTL Chr 8)
|
|
GS171251: HP:0003549 Abnormality of connective tissue
|
|
GS174337: HP:0002718 Recurrent bacterial infections
|
|
GS166862: MP:0000689 abnormal spleen morphology
|
|
GS207949: GO:0005996 monosaccharide metabolic process
|
|
GS84206: METH responses for body temperature (Published QTL, Chr 8)
|
|
GS169531: MP:0005391 vision/eye phenotype
|
|
GS136068: immune response to AAV2 QTL 2 (Imraq2, Published QTL Chr 8)
|
|
GS135913: glomerulsclerosis index 1 (Gsi1, Published QTL Chr 8)
|
|
GS172118: HP:0004332 Abnormality of lymphocytes
|
|
GS174505: HP:0000708 Behavioural/Psychiatric Abnormality
|
|
GS135613: circulating hormone level QTL 5 (Chlq5, Published QTL Chr 8)
|
|
GS165876: MP:0002135 abnormal kidney morphology
|
|
GS171144: HP:0005280 Depressed nasal bridge
|
|
GS165809: MP:0002864 abnormal ocular fundus morphology
|
|
GS172470: HP:0001743 Abnormality of the spleen
|
|
GS176477: HP:0002118 Abnormality of the cerebral ventricles
|
|
GS171849: HP:0000599 Abnormality of the frontal hairline
|
|
GS171627: HP:0000470 Short neck
|
|
GS175098: HP:0000284 Abnormality of the ocular region
|
|
GS173787: HP:0002813 Abnormality of limb bone morphology
|
|
GS86830: Table S2: List of probe-sets of genes differentially expressed among the four inbred strains of mice. C57BL/6J [DRG]
provisional
|
|
GS195214: GO:0009987 cellular process
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS200648: GO:0044260 cellular macromolecule metabolic process
|
|
GS175673: HP:0100022 Abnormality of movement
|
|
GS176627: HP:0000457 Flat nose
|
|
GS164798: MP:0008262 abnormal hippocampus region morphology
|
|
GS165135: MP:0003008 enhanced long term potentiation
|
|
GS171148: HP:0011218 Abnormal shape of the frontal region
|
|
GS172699: HP:0002652 Skeletal dysplasia
|
|
GS187166: GO:0044708 single-organism behavior
|
|
GS169225: MP:0000358 abnormal cell morphology
|
|
GS174917: HP:0000765 Abnormality of the thorax
|
|
GS174335: HP:0001871 Abnormality of blood and blood-forming tissues
|
|
GS175714: HP:0011389 Functional abnormality of the inner ear
|
|
GS163316: MP:0000035 abnormal membranous labyrinth morphology
|
|
GS86906: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by strain (3457). [DRG]
provisional
|
|
GS187654: GO:0016798 hydrolase activity, acting on glycosyl bonds
|
|
GS824: UCSD_CEREBELLUM_Int_Age_Geno
|
|
GS167534: MP:0009145 abnormal pancreatic acinus morphology
|
|
GS198263: GO:0005488 binding
|
|
GS136920: vertebral morphology and mechanical traits 8 (Vmmt8, Published QTL Chr 8)
|
|
GS86932: Table S3: CORTEX 17K MICROARRAY [DRG]
|
|
GS175169: HP:0001317 Abnormality of the cerebellum
|
|
GS192918: GO:0050896 response to stimulus
|
|
GS174236: HP:0000534 Abnormality of the eyebrow
|
|
GS125402: Diethylnitrosamine interacting genes (MeSH:D004052) in CTD
|
|
GS135397: body growth early QTL 7 (Bgeq7, Published QTL Chr 8)
|
|
GS170971: HP:0000407 Sensorineural hearing impairment
|
|
GS171559: HP:0000388 Otitis media
|
|
GS208037: GO:0016787 hydrolase activity
|
|
GS167140: MP:0003169 abnormal scala media morphology
|
|
GS136512: prion incubation time 3 (Pitm3, Published QTL Chr 8)
|
|
GS173287: HP:0000315 Abnormality of the orbital region
|
|
GS125403: Diethylstilbestrol interacting genes (MeSH:D004054) in CTD
|
|
GS135717: despair 1 (Desp1, Published QTL Chr 8)
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS175597: HP:0011013 Abnormality of carbohydrate metabolism/homeostasis
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS172353: HP:0004329 Abnormality of the posterior segment of the eye
|
|
GS169387: MP:0002062 abnormal associative learning
|
|
GS169639: MP:0002703 abnormal renal tubule morphology
|
|
GS135844: femoral cross-sectional area 2 (Fcsa2, Published QTL Chr 8)
|
|
GS124579: Selenium interacting genes (MeSH:D012643) in CTD
|
|
GS163706: MP:0000830 abnormal diencephalon morphology
|
|
GS136369: obesity QTL 16 (Obq16, Published QTL Chr 8)
|
|
GS183151: GO:0007611 learning or memory
|
|
GS165798: MP:0005367 renal/urinary system phenotype
|
|
GS174453: HP:0001438 Abnormality of the abdomen
|
|
GS180164: GO:0008150 biological_process
|
|
GS176333: HP:0007319 Morphological abnormality of the central nervous system
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS169829: MP:0005385 cardiovascular system phenotype
|
|
GS167748: MP:0000788 abnormal cerebral cortex morphology
|
|
GS35264: Whole Brain Gene expression correlates of Maximum startle response to 80 db in Females BXD
|
|
GS172260: HP:0000356 Abnormality of the outer ear
|
|
GS175994: HP:0000464 Abnormality of the neck
|
|
GS136355: novelty/stress induced locomotor activation 6 (Nsila6, Published QTL Chr 8)
|
|
GS199922: GO:0005975 carbohydrate metabolic process
|
|
GS165465: MP:0003633 abnormal nervous system physiology
|
|
GS172329: HP:0005469 Flat occiput
|
|
GS171258: HP:0011138 Abnormality of skin adnexa
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS173167: HP:0100491 Abnormality of the joints of the lower limbs
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS176924: HP:0000212 Gingival overgrowth
|
|
GS200602: GO:0044267 cellular protein metabolic process
|
|
GS125506: Valproic Acid interacting genes (MeSH:D014635) in CTD
|
|
GS164751: MP:0000607 abnormal hepatocyte morphology
|
|
GS124594: 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid interacting genes (MeSH:C472791) in CTD
|
|
GS171176: HP:0001547 Abnormality of the morphology of the rib cage
|
|
GS171907: HP:0004299 Hernia of the abdominal wall
|
|
GS176836: HP:0000422 Abnormality of the nasal bridge
|
|
GS866: Linear decrease in expression in both Pax6 (Sey) mutants and controls.
|
|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS166825: MP:0000462 abnormal digestive system morphology
|
|
GS169304: MP:0008251 abnormal phagocyte morphology
|
|
GS167249: MP:0008267 abnormal hippocampus CA3 region morphology
|
|
GS164220: MP:0002882 abnormal neuron morphology
|
|
GS163596: MP:0000026 abnormal inner ear morphology
|
|
GS172194: HP:0002970 Genu varum
|
|
GS201949: GO:0044699 single-organism process
|
|
GS172666: HP:0011804 Abnormality of muscle physiology
|
|
GS164269: MP:0000815 abnormal Ammon gyrus morphology
|
|
GS175107: HP:0003808 Abnormal muscle tone
|
|
GS181760: GO:0006013 mannose metabolic process
|
|
GS178461: GO:0009987 cellular process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS181665: GO:0048029 monosaccharide binding
|
|
GS175802: HP:0003272 Abnormality of the hip bone
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS192041: GO:0043169 cation binding
|
|
GS173384: HP:0002750 Delayed skeletal maturation
|
|
GS170108: MP:0003727 abnormal retinal layer morphology
|
|
GS173247: HP:0007957 Reduction of corneal clarity
|
|
GS191043: GO:0005996 monosaccharide metabolic process
|
|
GS173148: HP:0003712 Muscle hypertrophy
|
|
GS179830: GO:0006464 cellular protein modification process
|
|
GS167356: MP:0002207 abnormal long term potentiation
|
|
GS176004: HP:0100656 Thoracoabdominal wall defects
|
|
GS193268: GO:0005575 cellular_component
|
|
GS173868: HP:0002143 Abnormality of the spinal cord
|
|
GS165610: MP:0008989 abnormal liver sinusoid morphology
|
|
GS192920: GO:0050890 cognition
|
|
GS171902: HP:0010987 Abnormality of cellular immune system
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS172891: HP:0100538 Abnormality of the supraorbital ridges
|
|
GS172032: HP:0000366 Abnormality of the nose
|
|
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
|
|
GS175193: HP:0002062 Abnormality of the pyramidal tracts
|
|
GS170956: HP:0005619 Thoracolumbar kyphosis
|
|
GS163320: MP:0000031 abnormal cochlea morphology
|
|
GS165466: MP:0003632 abnormal nervous system morphology
|
|
GS165528: MP:0005379 endocrine/exocrine gland phenotype
|
|
GS172471: HP:0001744 Splenomegaly
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS196595: GO:0006464 cellular protein modification process
|
|
GS136061: immunoregulatory 3 (Im3, Published QTL Chr 8)
|
|
GS167537: MP:0009146 abnormal pancreatic acinar cell morphology
|
|
GS184566: GO:0019538 protein metabolic process
|
|
GS125104: Ethionine interacting genes (MeSH:D005001) in CTD
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS173751: HP:0000998 Hypertrichosis
|
|
GS191106: GO:0044464 cell part
|
|
GS170981: HP:0011361 Congenital abnormal hair pattern
|
|
GS172031: HP:0000364 Hearing abnormality
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS170580: MP:0008986 abnormal liver parenchyma morphology
|
|
GS171959: HP:0000400 Macrotia
|
|
GS175835: HP:0007759 Opacification of the corneal stroma
|
|
GS174378: HP:0000518 Cataract
|
|
GS175131: HP:0000023 Inguinal hernia
|
|
GS168579: MP:0003635 abnormal synaptic transmission
|
|
GS171884: HP:0003133 Abnormality of the spinocerebellar tracts
|
|
GS174187: HP:0001595 Abnormality of the hair
|
|
GS203688: GO:0008270 zinc ion binding
|
|
GS198550: GO:0006013 mannose metabolic process
|
|
GS176612: HP:0000272 Malar flattening
|
|
GS173146: HP:0011282 Abnormality of the hindbrain
|
|
GS175301: HP:0000294 Low anterior hairline
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS135883: femur geometry 7 (Fmgty7, Published QTL Chr 8)
|
|
GS192230: GO:0005773 vacuole
|
|
GS173137: HP:0011821 Abnormality of facial skeleton
|
|
GS172134: HP:0000639 Nystagmus
|
|
GS208978: GO:0043169 cation binding
|
|
GS87378: Table S2: The data provided represent genes showing differential expression using ANOVA. (Whole Table) [DRG]
provisional
|
|
GS176488: HP:0010720 Abnormal hair pattern
|
|
GS174920: HP:0000766 Abnormality of the sternum
|
|
GS136572: radiation induced acute myeloid leukemia 4 (Raml4, Published QTL Chr 8)
|
|
GS1140: Differential expression in brain of 22TNJ, a high alcohol-induced locomotor activation mutant
|
|
GS179873: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compounds
|
|
GS172916: HP:0003312 Abnormal form of the vertebral bodies
|
|
GS169828: MP:0005386 behavior/neurological phenotype
|
|
GS191074: GO:0005764 lysosome
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS169832: MP:0005381 digestive/alimentary phenotype
|
|
GS166244: MP:0002752 abnormal somatic nervous system morphology
|
|
GS167755: MP:0000783 abnormal forebrain morphology
|
|
GS174308: HP:0002979 Bowing of the legs
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS171296: HP:0008897 Postnatal growth retardation
|
|
GS167651: MP:0001944 abnormal pancreas morphology
|
|
GS189860: GO:0043167 ion binding
|
|
GS174217: HP:0005105 Abnormal nasal morphology
|
|
GS169631: MP:0004166 abnormal limbic system morphology
|
|
GS174909: HP:0000546 Retinal degeneration
|
|
GS175558: HP:0002516 Increased intracranial pressure
|
|
GS180521: GO:0000323 lytic vacuole
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS125040: Thioacetamide interacting genes (MeSH:D013853) in CTD
|
|
GS173079: HP:0000496 Abnormality of eye movement
|
|
GS165386: MP:0001262 decreased body weight
|
|
GS165535: MP:0005370 liver/biliary system phenotype
|
|
GS191448: GO:0004559 alpha-mannosidase activity
|
|
GS164962: MP:0002855 abnormal cochlear ganglion morphology
|
|
GS168692: MP:0004288 abnormal spiral ligament morphology
|
|
GS135259: autoimmune extremity vasculitis in MRL mice 1 (Aevm1, Published QTL Chr 8)
|
|
GS177031: HP:0011442 Abnormality of central motor function
|
|
GS837: Sey_Pax6_Add_Up_Para
|
|
GS172354: HP:0004328 Abnormality of the anterior segment of the eye
|
|
GS174178: HP:0100774 Hyperostosis
|
|
GS168996: MP:0009643 abnormal urine homeostasis
|
|
GS174836: HP:0001098 Abnormality of the fundus
|
|
GS123351: Omeprazole interacting genes (MeSH:D009853) in CTD
|
|
GS169129: MP:0002446 abnormal macrophage morphology
|
|
GS176170: HP:0001252 Muscular hypotonia
|
|
GS172680: HP:0003302 Spondylolisthesis
|
|
GS165869: MP:0002138 abnormal hepatobiliary system morphology
|
|
GS174899: HP:0100886 Abnormality of globe location
|
|
GS167300: MP:0001460 abnormal olfactory -discrimination memory
|
|
GS166486: MP:0005301 abnormal corneal endothelium morphology
|
|
GS172433: HP:0002644 Abnormality of pelvic girdle bone morphology
|
|
GS166123: MP:0002102 abnormal ear morphology
|
|
GS174948: HP:0100763 Abnormality of the lymphatic system
|
|
GS186067: GO:0050877 neurological system process
|
|
GS195021: GO:0006517 protein deglycosylation
|
|
GS124711: Genistein interacting genes (MeSH:D019833) in CTD
|
|
GS176803: HP:0001260 Dysarthria
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS193018: GO:0003008 system process
|
|
GS164163: MP:0005058 abnormal lysosome morphology
|
|
GS169767: MP:0002396 abnormal hematopoietic system morphology/development
|
|
GS184447: GO:0044424 intracellular part
|
|
GS171394: HP:0000174 Abnormality of the palate
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS166513: MP:0008195 abnormal antigen presenting cell morphology
|
|
GS174230: HP:0000303 Mandibular prognathia
|
|
GS165565: MP:0001462 abnormal avoidance learning behavior
|
|
GS136300: mean platelet volume locus 2 (Mpvq2, Published QTL Chr 8)
|
|
GS164526: MP:0000807 abnormal hippocampus morphology
|
|
GS172815: HP:0000337 Broad forehead
|
|
GS171448: HP:0000606 Abnormality of the periorbital region
|
|
GS182234: GO:0036211 protein modification process
|
|
GS166029: MP:0000960 abnormal sensory ganglion morphology
|
|
GS196679: GO:0030246 carbohydrate binding
|
|
GS210212: GO:0005575 cellular_component
|
|
GS135466: blood pressure QTL 23 (Bpq23, Published QTL Chr 8)
|
|
GS176202: HP:0000479 Abnormality of the retina
|
|
GS173020: HP:0000818 Abnormality of the endocrine system
|
|
GS170894: HP:0006487 Bowing of the long bones
|
|
GS163818: MP:0002722 abnormal immune system organ morphology
|
|
GS136672: skull morphology 11 (Skull11, Published QTL Chr 8)
|
|
GS121370: Clofibrate interacting genes (MeSH:D002994) in CTD
|
|
GS183803: GO:0044267 cellular protein metabolic process
|
|
GS176801: HP:0001263 Global developmental delay
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS168149: MP:0005508 abnormal skeleton morphology
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS165616: MP:0002127 abnormal cardiovascular system morphology
|
|
GS172814: HP:0000336 Prominent supraorbital ridges
|
|
GS182834: GO:0005623 cell
|
|
GS176167: HP:0001257 Spasticity
|
|
GS196642: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compounds
|
|
GS174914: HP:0003011 Abnormality of the musculature
|
|
GS167922: MP:0000959 abnormal somatic sensory system morphology
|
|
GS171217: HP:0003487 Babinski sign
|
|
GS166710: MP:0002163 abnormal gland morphology
|
|
GS196943: GO:0008152 metabolic process
|
|
GS168838: MP:0003107 abnormal response to novelty
|
|
GS169277: MP:0001081 abnormal cranial ganglia morphology
|
|
GS199634: GO:0005623 cell
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS166117: MP:0002108 abnormal muscle morphology
|
|
GS167357: MP:0002206 abnormal CNS synaptic transmission
|
|
GS173563: HP:0000692 Misalignment of teeth
|
|
GS173743: HP:0001999 Abnormal facial shape
|
|
GS176613: HP:0000271 Abnormality of the face
|
|
GS175928: HP:0000240 Abnormality of skull size
|
|
GS170825: HP:0002167 Neurological speech impairment
|
|
GS168551: MP:0002429 abnormal blood cell morphology/development
|
|
GS135252: adiposity 4 (Adip4, Published QTL Chr 8)
|
|
GS172250: HP:0000943 Dysostosis multiplex
|
|
GS175805: HP:0003271 Visceromegaly
|
|
GS175902: HP:0003468 Abnormality of the vertebrae
|
|
GS175981: HP:0000163 Abnormality of the oral cavity
|
|
GS129101: bone mineral density 39 (Bmd39 Published QTL Chr 8)
|
|
GS176100: HP:0000925 Abnormality of the vertebral column
|
|
GS171848: HP:0000598 Abnormality of the ear
|
|
GS172516: HP:0001347 Hyperreflexia
|
|
GS213073: Genes with suggestive difference in (PB6F1) vs (B6PF1 + B6 + PWD) comparison
|
|
GS167527: MP:0005300 abnormal corneal stroma morphology
|
|
GS168157: MP:0005504 abnormal ligament morphology
|
|
GS135780: exercise endurance QTL 2 (Eeq2, Published QTL Chr 8)
|
|
GS121771: Benzbromarone interacting genes (MeSH:D001553) in CTD
|
|
GS175113: HP:0000574 Thick eyebrow
|
|
GS163971: MP:0002092 abnormal eye morphology
|
|
GS172910: HP:0007163 Corticospinal tract disease in lower limbs
|
|
GS185104: GO:0019318 hexose metabolic process
|
|
GS174462: HP:0002648 Abnormality of calvarial morphology
|
|
GS165397: MP:0001265 decreased body size
|
|
GS176185: HP:0100790 Hernia
|
|
GS202899: GO:0050877 neurological system process
|
|
GS172030: HP:0000365 Hearing impairment
|
|
GS172021: HP:0001367 Abnormal joint morphology
|
|
GS173901: HP:0002007 Frontal bossing
|
|
GS203594: GO:0043226 organelle
|
|
GS169677: MP:0006007 abnormal basal ganglion morphology
|
|
GS136755: susceptibility to Salmonella typhimurium antigens 6 (Ssta6, Published QTL Chr 8)
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS171168: HP:0000234 Abnormality of the head
|
|
GS171908: HP:0004298 Abnormality of the abdominal wall
|
|
GS165537: MP:0005376 homeostasis/metabolism phenotype
|
|
GS167622: MP:0002152 abnormal brain morphology
|
|
GS209960: GO:0003008 system process
|
|
GS167585: MP:0001417 decreased exploration in new environment
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS171346: HP:0002846 Abnormality of B cells
|
|
GS201922: GO:0019318 hexose metabolic process
|
|
GS199951: GO:0007611 learning or memory
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS194087: GO:0003674 molecular_function
|
|
GS171424: HP:0002814 Abnormality of the lower limb
|
|
GS204516: GO:0016798 hydrolase activity, acting on glycosyl bonds
|
|
GS171602: HP:0001965 Abnormality of the scalp
|
|
GS171793: HP:0000377 Abnormality of the pinna
|
|
GS172839: HP:0010674 Abnormality of the curvature of the vertebral column
|
|
GS170131: MP:0008415 abnormal neurite morphology
|
|
GS194336: GO:0043412 macromolecule modification
|
|
GS165985: MP:0000965 abnormal sensory neuron morphology
|
|
GS180166: GO:0008152 metabolic process
|
|
GS165114: MP:0004426 abnormal cochlear labyrinth morphology
|
|
GS176964: HP:0011217 Abnormal shape of the occiput
|
|
GS168592: MP:0003634 abnormal glial cell morphology
|
|
GS175974: HP:0004493 Craniofacial hyperostosis
|
|
GS183122: GO:0005975 carbohydrate metabolic process
|